MIR873 Gene

HGNC Family Non-coding RNAs
Name microRNA 873
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nA growing body of evidence indicates that miR‐873 (often referred to as miR‐873‑5p) plays context‐dependent roles in human disease, with a predominant tumor‑suppressive function in many cancers. In breast cancer, enforced expression of miR‑873 was shown to inhibit cell proliferation by targeting cell cycle regulators such as cyclin‑dependent kinase 3, while in glioblastoma and colorectal cancer its low expression correlated with aggressive phenotypes by failing to downregulate oncogenic targets like IGF2BP1 and TRAF5/TAB1 respectively. Likewise, in esophageal and cervical cancers, restoration of miR‑873 levels suppressed tumor cell growth, migration, and invasion by directly targeting genes including DEC2 and CXCL5/p53 modulators. In ovarian cancer, miR‑873 enhanced chemosensitivity by lowering MDR1 (ABCB1) expression, and in non‑small cell lung cancer (NSCLC) and bladder cancer, miR‑873 negatively regulated molecules involved in proliferation and metastatic signaling."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to curbing tumor aggressiveness, miR‑873 modulates cellular responses to chemotherapeutic agents by influencing drug resistance pathways. In glioma cells resistant to cisplatin, overexpression of miR‑873 re‐sensitized cells through downregulation of the anti‑apoptotic Bcl‑2, whereas in ovarian cancer its upregulation reduced MDR1 expression and enhanced sensitivity to cisplatin and paclitaxel. Moreover, under high‑altitude hypoxic conditions, decreased miR‑873‑5p contributes to the elevation of drug transporter expression, suggesting that manipulation of miR‑873 may reverse chemoresistance in certain settings."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA number of studies have also unveiled that miR‑873 operates within intricate competing endogenous RNA (ceRNA) networks. In several tumors, long non‑coding RNAs (lncRNAs) such as GAS5, DDX11‑AS1, TDRG1, and ERVK13‑1 have been reported to act as molecular “sponges” for miR‑873‑5p, thereby releasing its downstream targets from repression. In hepatocellular carcinoma, for instance, miR‑873 targeting of TRIM25 and PHF2 is attenuated by ceRNA interactions, which contributes to enhanced tumor cell migratory and invasive capacities. Similar ceRNA‑mediated regulatory mechanisms have been implicated in osteosarcoma and other settings, underscoring the complexity of miR‑873’s regulatory network."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond malignancies, miR‑873 influences diverse biological processes in non‑cancer settings. In systemic lupus erythematosus (SLE), increased miR‑873 expression in CD4⁺ T cells promotes their differentiation towards the pro‑inflammatory Th17 lineage by targeting the transcription factor Foxo1, thereby exacerbating disease severity. Furthermore, in congenital heart disease, elevated circulating miR‑873 inhibits cardiomyocyte proliferation via targeting GLI1, and in endothelial cells, modulation of miR‑873 by the lncRNA UCA1 impacts oxidative stress and inflammatory responses through the MAPK8 signaling pathway."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies in NSCLC, hepatocellular carcinoma, and papillary thyroid cancer further reinforce the multifaceted roles of miR‑873. Investigations in NSCLC indicate that miR‑873 regulates proliferation, invasion, and even chemoresistance—through modulation of the YWHAE/PI3K/AKT axis—while in HCC and thyroid cancer its dysregulation is linked with altered expression of key oncogenic proteins. Collectively, these findings highlight miR‑873 as a promising prognostic biomarker and potential therapeutic target across an array of human diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J Cui, Y Yang, H Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.430"}], "href": "https://doi.org/10.1038/onc.2014.430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25531331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25531331"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ren-jie Wang, Jian-wei Li, Bu-he Bao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.624700"}], "href": "https://doi.org/10.1074/jbc.M114.624700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25670861"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25670861"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiong Chen, Yingying Zhang, Yingying Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2015.3143"}], "href": "https://doi.org/10.3892/ijo.2015.3143"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26323558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26323558"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Di-di Wu, Xue-Song Li, Xiao-Na Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-4944-y"}], "href": "https://doi.org/10.1007/s13277-016-4944-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26850595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26850595"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hui Gong, Lishan Fang, Yifan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2018.6199"}], "href": "https://doi.org/10.3892/or.2018.6199"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29328486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29328486"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yuqiang Liang, Peirong Zhang, Shaohong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.05.152"}], "href": "https://doi.org/10.1016/j.biopha.2018.05.152"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29890466"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29890466"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hai-Xia Liang, Yu-Hong Li "}, {"type": "b", "children": [{"type": "t", "text": "MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Genomics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13258-019-00905-8"}], "href": "https://doi.org/10.1007/s13258-019-00905-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31902110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31902110"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wang Chang, Qing Chang, Haodong Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-873-5p suppresses cell malignant behaviors of thyroid cancer via targeting CXCL5 and regulating P53 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Vaccin Immunother (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21645515.2022.2065837"}], "href": "https://doi.org/10.1080/21645515.2022.2065837"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35486941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35486941"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Shingo Kishi, Shiori Mori, Rina Fujiwara-Tani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms242216367"}], "href": "https://doi.org/10.3390/ijms242216367"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38003554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38003554"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhifeng Li, Jinglei Liu, Ping Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel miR-873-5p-YWHAE-PI3K/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Funct Integr Genomics (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10142-024-01295-1"}], "href": "https://doi.org/10.1007/s10142-024-01295-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38363382"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38363382"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yabin Duan, Xue Bai, Jianxin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exposure to High-Altitude Environment Is Associated with Drug Transporters Change: microRNA-873-5p-Mediated Alteration of Function and Expression Levels of Drug Transporters under Hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.121.000681"}], "href": "https://doi.org/10.1124/dmd.121.000681"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34844996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34844996"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jin-Ying Wei, Qiang Zhang, Yue Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circTTBK2 facilitates non-small-cell lung cancer malignancy through the miR-873-5p/TEAD1/DERL1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi-2021-0480"}], "href": "https://doi.org/10.2217/epi-2021-0480"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35916080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35916080"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Liujun Chen, Lang Chen, Luoshiyuan Zuo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Short Communication: Long Noncoding RNA GAS5 Inhibits HIV-1 Replication Through Interaction with miR-873."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "AIDS Res Hum Retroviruses (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/AID.2017.0177"}], "href": "https://doi.org/10.1089/AID.2017.0177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29620929"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29620929"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yu-Hui Li, Ming Zhong, Hong-Liang Zang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2018.04.010"}], "href": "https://doi.org/10.1016/j.yexcr.2018.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29654742"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29654742"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yan Ma, Xiu Lian Xu, Hai Ge Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA TDRG1 promotes the aggressiveness of gastric carcinoma through regulating miR-873-5p/HDGF axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109425"}], "href": "https://doi.org/10.1016/j.biopha.2019.109425"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31726370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31726370"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Han Xie, Libing Dai, Baoqing Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ERVK13-1 aggravates osteosarcoma through the involvement of microRNA-873-5p/KLF5 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Pol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18388/abp.2020_5809"}], "href": "https://doi.org/10.18388/abp.2020_5809"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36272150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36272150"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Lan Peng, Jian Chen, Min Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_MBNL3 Restrains Hepatocellular Carcinoma Progression by Sponging miR-873-5p to Release PHF2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-022-10295-4"}], "href": "https://doi.org/10.1007/s10528-022-10295-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36380035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36380035"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jing-Shu Zhang, Yue Zhao, Yuan Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-873 suppresses H9C2 cardiomyocyte proliferation by targeting GLI1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.05.062"}], "href": "https://doi.org/10.1016/j.gene.2017.05.062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28583401"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28583401"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lining Liu, Yifan Liu, Min Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.08.075"}], "href": "https://doi.org/10.1016/j.bbrc.2017.08.075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28837808"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28837808"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Shu-Xin Zhang, Cheng-Hong Yu "}, {"type": "b", "children": [{"type": "t", "text": "Silencing of UCA1 attenuates the ox-LDL-induced injury of human umbilical vein endothelial cells via miR-873-5p/MAPK8 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kaohsiung J Med Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/kjm2.12612"}], "href": "https://doi.org/10.1002/kjm2.12612"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36326096"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36326096"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Guoyong Han, Long Zhang, Xuhao Ni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000489594"}], "href": "https://doi.org/10.1159/000489594"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29734164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29734164"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Shidai Jin, Jing He, Jun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.12830"}], "href": "https://doi.org/10.1111/1759-7714.12830"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30126075"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30126075"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Tong Wu, Da-Lin Zhang, Jia-Mei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-03018-3"}], "href": "https://doi.org/10.1038/s41419-020-03018-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32994394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32994394"}]}]}]}
Synonyms HSA-MIR-873, MIRN873, MIR-873
NCBI Gene ID 100126316
API
Download Associations
Predicted Functions View MIR873's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR873's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR873's ARCHS4 Predicted Functions.

Functional Associations

MIR873 has 256 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for MIR873 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR873 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR873 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR873 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR873 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR873 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR873 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR873 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR873 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR873 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR873 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR873 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR873 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.